• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

DRRX:US

1.5800 USD 0.0200 1.25%

As of 11:55:40 ET on 08/28/2014.

Snapshot for Durect Corp (DRRX)

Open: 1.5800 Day's Range: 1.5600 - 1.6000 Volume: 21,191
Previous Close: 1.6000 52wk Range: 1.0700 - 2.6900 1-Yr Rtn: +43.64%

Stock Chart for DRRX

No chart data available.
  • DRRX:US 1.5799
  • 1D
  • 1M
  • 1Y
1.6000
Interactive DRRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1900
Est. EPS (USD) (12/2014) -0.1900
Est. PEG Ratio -
Market Cap (M USD) 175.21
Shares Outstanding (M) 111.60
30 Day Average Volume 163,579
Price/Book (mrq) 7.0346
Price/Sale (ttm) 9.4175
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DRRX

Durect Corporation develops and commercializes pharmaceutical systems for the treatment of chronic diseases. The pharmaceutical systems provide therapy for chronic diseases or conditions by replacing multiple injection therapy or oral dosing, improving drug efficacy, reducing side effects, and ensuring dosing compliance.

Felix TheeuwesChairman/Chief Scientific OfcrJames E BrownPresident/CEO/Co-Founder
Matthew J HoganChief Financial OfficerSu Il YumExec VP:Pharmaceutical Sys
More Company Profile & Key Executives for DRRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil